NOT:ETR
Novartis
124,98 €
arrow_upward
+0,05%(+0,060) 1 d.
6. 10., 17:35:47 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NOT…
Otvoriť
126,62 €
Vysoká
126,98 €
Nízka
124,44 €
Trh. kap.
285,54 mld.
Priem. obj.
6,54 tis.
Objem
4,29 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Otvoriť
126,62 €
Vysoká
126,98 €
Nízka
124,44 €
Trh. kap.
285,54 mld.
Priem. obj.
6,54 tis.
Objem
4,29 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
GuruFocus
·
pred 13 minútami
Novartis Stocks Stay Flat as $575 Million RNA Bet Opens $7.2 Bil
AD HOC NEWS
·
pred 3 hodinami
Novartis stock last at EUR 125.56 on Tradegate on October 6, 2026
AD HOC NEWS
·
pred 1 dňom
Novartis stock gets a USD 575 million mRNA deal
AD HOC NEWS
·
pred 1 dňom
Novartis signs USD 7.8 billion Abogen deal: 20 analysts rate Novartis stock Hold
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Informácie o subjekte Novartis
Generálny riaditeľVasant Narasimhan
Zamestnanci75,3 tis.
Dátum založenia7. 3. 1996
Hlavné sídloBazilej, Bazilej-mesto, Švajčiarsko
Odvetvie-
Webnovartis.com